DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Earnings call for Q1 FY2431-07-2023
31-07-2023
Buy Dr Reddys Labs; target of Rs 6560: KR Choksey
KR Choksey is bullish on Dr Reddys Labs has recommended buy rating on the stock with a target price of Rs 6560 in its research report dated July 28, 2023.31-07-2023
Reduce Dr. Reddy's Laboratories; target of Rs 5150: Prabhudas Lilladher
Prabhudas Lilladher recommended hold rating on Dr. Reddy's Laboratories with a target price of Rs 5150 in its research report dated July 27, 2023.29-07-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Outcome of 39th AGM- scrutinizer''s report28-07-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 39th AGM28-07-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of share certificate28-07-2023
Dr Reddy Share Price Live blog for 28 Jul 2023
Dr Reddy stock price went up today, 28 Jul 2023, by 0.5 %. The stock closed at 5476.5 per share. The stock is currently trading at 5504.15 per share. Investors should monitor Dr Reddy stock price closely in the coming days and weeks to see how it reacts to the news.28-07-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation About Filing Of Form 6K For Quarter Ended June 30, 2023
Intimation about filing of Form 6k for quarter ended June 30, 2023.27-07-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication for Q1 FY24 unaudited financial results27-07-2023
Dr Reddy share price hits 52-week high on strong Q1 results, but brokerages have mixed view; here's why
Dr Reddy's share price reached a 52-week high after the company reported strong Q1 results. Brokerages have mixed views with Nuvama Equities recommending a reduce' rating and Motilal Oswal maintaining a 'neutral' stance.27-07-2023